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ObituaryWilliam E. Paul, M.D. (1936–2015)Science is a tapestry made from many
small threads of information. When these
strands are woven together in the right or-
der, they produce images revealing the
underlying patterns of the natural world.
A few select scientists are not merely con-
tributors of these threads, but are
weavers of the tapestry, giving form and
meaning to the pieces of information
they and others contribute.
William E. Paul (Bill to most of us), who
passed away on September 18, 2015, at
age 79, was such a weaver. Through a
combination of enormous intellect,
remarkable focus, and experimental rigor,
hemade observations key to developing a
larger picture of adaptive immunity. But it
was not just such bench-based science
that distinguishedBill, notmerely the sem-
inal contributions he made through the
discovery of interleukin-4 (IL-4) and expo-
sition of the basis for T cell effector differ-
entiation, nor the erudite discussions in his
primary papers or the insightful sum-
maries in his reviews—Bill did not limit
himself to reporting what he observed,
but also applied his formidable mind to
developing generalizations about how
the immune system functioned in a larger
context. The resulting hypotheses stand
out as exemplars of the deep thinking—
of the weaving—that brings form to the
parcels of knowledgegleaned fromexper-
imentation. Whether dealing with how
T cells set thresholds for antigen discrimi-
nation or how regulatory processes inter-
weave with this cell intrinsic behavior to
generate a properly controlled immune
system, Bill was unique in blending such
hypothetical analyses with the most strin-
gent of experimental studies.
Bill was born in Brooklyn in 1936 and
considered his education at local public
institutions a point of pride, having done
his undergraduate work at Brooklyn Col-
lege and his medical degree at SUNY
Downstate. This was followed by resi-
dency in Boston at Massachusetts Me-
morial Hospitals (now Boston Medical
Center) where he did research on
amyloidosis that led to his first of more
than 600 scientific publications, with this
initial one in Nature.
Bill then came to the National Institutes
of Health (NIH) for a combined clinical andresearch stint in the Endocrinology
Branch of the National Cancer Institute
(NCI). He treated womenwith choriocarci-
noma with the drug methotrexate, which
had just been recently developed, curing
a large fraction of patients with advanced,
otherwise lethal disease. He also worked
in the laboratory, pioneering the develop-
ment of radioimmunoassays for gonado-
tropins and other hormones.
Although Bill found these activities
extremely gratifying, he had already
been bitten by the immunology bug years
earlier upon reading a book by Michael
Heidelberger. To get the training he felt
he needed in this subject, he asked advice
from several Boston area immunologists
and was pointed to Henry Kunkel and
Baruj Benacerraf in New York City. Fortu-
nately for all of us, Baruj offered Bill a po-
sition, and Bill started working at New
York University (NYU) with Benacerraf in
1964, in the midst of the research on the
genetics of immunity that later led to BarujImmunity 43receiving the 1980 Nobel Prize in Medi-
cine or Physiology.
Bill came to the National Institute of
Allergy and Infectious Disease (NIAID) at
NIH in 1968 together with Benacerraf
when Baruj became Chief of the Labora-
tory of Immunology (LI), an already
renowned department previously led by
Jules Freund (of Freund’s adjuvant fame).
Baruj left after 2 years to become Chair
of Pathology at Harvard, which provided
Bill the opportunity to become his succes-
sor as Chief of the LI in 1970, a position Bill
held until his death. Under Bill’s guidance,
and in large measure through the extraor-
dinary contributions of his own laboratory,
the LI became recognized as a leading
center of immunology. Beyond Bill’s con-
tributions as an investigator, his astute
guidance of the department, especially
his persistently positive attitude, his gen-
erosity with research support, and his will-
ingness to allow maximum independence
of his colleagues—within what at that, October 20, 2015 ª2015 Elsevier Inc. 617
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mental structure at NIH—empowered
those he recruited to undertake creative
and often risky but ultimately rewarding
research paths.
Bill’s contributions to immunology were
extraordinary, including the discovery of
IL-4 (initially called BSF-1) with Maureen
Howard, elucidating the molecular basis
of IL-4 signaling, dissecting the molecular
genetic control of expression of IL-4 and
other Th2 cell cytokines, and delineating
the general principle of positive cytokine
feedback regulation of CD4+ T cell
effector polarization. Beyond this core
effort on IL-4 and Th2 cell biology, Bill
made seminal contributions to our under-
standing of how immunoglobulin produc-
tion and class selection are controlled, the
basis for MHC-restricted recognition of
antigen by T cells, the regulation of cell
proliferation and clonality in lymphopenic
animals, and the role of mast cells and ba-
sophils in cytokine production. In addi-
tion, with his long-standing colleague Zvi
Grossman, Bill produced enormously
insightful and impactful treatises on im-
mune regulation, from how thresholds
are set for antigen-driven responsiveness
to how regulatory T cells function.
Beyond his remarkable combination of
broad knowledge, creative thinking, and
rigorous experimentation, Bill also had
other very special attributes that set him
apart and contributed to the enormous
respect he attained around the world.
First,while hehad the strongegoanddrive
necessary for success in a competitive
environment, he did not abuse his position
for self-advancement. Indeed, he gener-
ously used the resources he commanded
to support the research efforts and career
development of others, a characteristic
crucial to all the members of the Labora-
tory of Immunology during his long and
extremely successful tenure as Lab Chief.
In addition, Bill’s generosity extendedwell
beyond the LI and NIAID. Both within and
outside the NIH community, he provided
insightful advice on both scientific and
career advancement issues. This selfless-
ness was underscored by how he treated
members of his own research group who
were at vulnerable stages of their careers,
often maximizing the credit they deserved
while diminishing his. After being nomi-
nated by Bill for an honor or award, if one
thanked him for his efforts, Bill’s typical
response was to instead underscore that618 Immunity 43, October 20, 2015 ª2015 Elhe was the one who was honored by hav-
ing the opportunity to nominate the indi-
vidual. Bill was also theonewhowasquick
to highlight accomplishments of NIH im-
munologists in emails to the NIH immu-
nology community or to raise a toast at
meetings to honor the organizers for their
hard work on everyone’s behalf. This gen-
erosity further enhanced Bill’s high stand-
ing among his peers.
Some scientists find it difficult to dedi-
cate the time and energy required to
have an impact on the community at
large, beyond their experimental contri-
butions to the field. Bill was quite the
opposite. He served on many advisory
boards, efforts that frequently required
travel and extended preparation for re-
views of departments or institutions, and
hence, time away from his laboratory
and family, to which he was so devoted.
He also played crucial roles in panels
deciding on recipients of major scientific
prizes, contributing his broad knowledge,
deep expertise, and always sage advice
to these important deliberations. More-
over, for more than 3 decades he was
the chief editor of the Annual Review of
Immunology, which under his guidance
became for a time the most cited publica-
tion in biomedical science. Bill also edited
seven editions of Fundamental Immu-
nology, which arguably has been the
most definitive reference in immunology
since its inception. Those of us who wrote
chapters for the book know that Bill edited
each one with thoughtful suggestions,
perhaps making Bill the only one in thesevier Inc.world who took the time to read carefully
every chapter of the massive tome he
fostered.
Bill was the NIH scientist tapped to form
a group to take over the editorship of Im-
munity from the Washington University
editors, making NIH the last group of
such non-professional editors of this jour-
nal. Bill invited the four of us to join him as
Editors and made clear that all of us
should be equal co-Editors, although we
all saw him as the unofficial leader of our
editorial board. His encyclopedic knowl-
edge of immunology, as well as the judi-
cious and generous spirit he always
showed toward authors, played an essen-
tial role in ensuring that Immunity pub-
lished the best possible science during
the period of our service and that those
submitting papers felt their research had
been given a fair, but rigorous, evaluation.
Bill always initially focused on what was
potentially novel and exciting in studies
and then how limitations or missing con-
trols might be fixed, placing emphasis
on the ‘‘good’’ before considering the
flaws.
When one combines these activities
with Bill’s contributions to organizations
such as the American Association of Im-
munologists (AAI) and American Society
for Clinical Investigation (ASCI), both of
which he served as President, his work
on other editorial boards, and his efforts
in official positions such as head of the
NIH Office of AIDS Research (OAR), one
sees the broad nature of Bill Paul’s impact
on science at all levels. The vast majority
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nor of great value to his personal
advancement, but represented invest-
ments in the larger scientific enterprise
to which he was so devoted on an interna-
tional scale. Indeed, he has been widely
praised for his oversight of the OAR, and
those active in the HIV/AIDS community
credit Bill’s wise leadership at an espe-
cially difficult time with helping accelerate
the development of anti-HIV drugs that
have saved millions of lives.
Bill was also a remarkable mentor. He
worked ceaselessly to provide all of his
fellows with the very best environment
and advice possible to develop their tal-
ents and promote their careers. Even to
those long gone from the lab and having
achieved independent distinction, he re-
mained a source of advice, support,
and wisdom. For those outside his
group, he also was a mentor of sorts.
He had a special ability to explore the
depths of a study presented at a lecture
through questions that frequently uncov-
ered aspects missed by the investigator.
He was justly famous for being able toask the most probing questions and yet
make the recipient feel like he or she
was receiving an accolade, a reflection
of Bill’s modesty about his remarkable
intellect.
In short, Bill Paul was the scientist’s sci-
entist. He had endless curiosity, an ability
to remain focused on unraveling layer af-
ter layer of complexity in biology without
losing his enthusiasm for the subject,
and devotion to the careers of others
and to the scientific enterprise as a whole.
As noted above, some scientists merely
add threads to the tapestry of biology,
but with Bill’s passing, we have lost a
master weaver who was brilliant at seeing
the essential patterns in the fabric of na-
ture. For this special capacity, for his lead-
ership, and for his friendship, he will be
missed tremendously.
Despite his passing, Bill has provided
one final gift to our field in his new book,
aptly titled ‘‘Immunity’’ and just published
in September 2015. He wrote this book
‘‘to introduce both the general readers
and potential students of immunology’’
to the field. Who better to do this thanImmunity 43Bill Paul, an extraordinary scientist,
mentor, friend, and ‘‘mensch.’’
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